{"id":"W6958261821","doi":"10.6084/m9.figshare.12655460","title":"Additional file 1 of Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapy","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Myeloid leukemia; Cytarabine; Complete response; Disease; Ruxolitinib; Overall survival; Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00003783088,0.000164422,0.0002767714,0.00003844409,0.00003629638,0.00001405051,0.00009062841,0.00007599311,0.02676712],"category_scores_gemma":[0.001236099,0.0001226494,0.00002976932,0.0001439218,0.00001842062,0.00000534277,0.000134083,0.00007274989,0.00001812258],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001429737,"about_ca_system_score_gemma":0.00009470565,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004547269,"about_ca_topic_score_gemma":0.00003396291,"domain_scores_codex":[0.9991075,0.00005075652,0.0001944168,0.0003618525,0.0001284221,0.0001570496],"domain_scores_gemma":[0.9991953,0.0003218376,0.00006892288,0.0001314669,0.0001373577,0.0001450602],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.02709895,0.0002071033,0.221604,0.0000765958,0.0006699747,0.00005612277,0.0003552005,0.0001060612,0.006544955,2.447952e-7,0.7367415,0.006539274],"study_design_scores_gemma":[0.002361921,0.0029072,0.9614869,0.0004549728,0.00000879922,0.000001065218,0.00005806929,0.00001130624,0.001979314,2.613619e-7,0.03050314,0.0002270707],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5379469,0.000009690337,2.570915e-7,0.00005701306,0.000002378691,0.0001653369,0.4617996,0.00000532968,0.00001342653],"genre_scores_gemma":[0.6953717,0.000004758937,0.0004974075,0.0007222242,0.00005161754,0.0002422759,0.3029834,0.00003252034,0.00009410925],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7398828,"threshold_uncertainty_score":0.9741225,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02578112239319292,"score_gpt":0.266591707720516,"score_spread":0.2408105853273231,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}